| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
3'-beta-C-Ethynyluridine manufacturers
|
| | 3'-beta-C-Ethynyluridine Basic information |
| Product Name: | 3'-beta-C-Ethynyluridine | | Synonyms: | 3'-?C-Ethynyluridine;3'-beta-C-Ethynyluridine;Uridine, 3'-C-ethynyl-;3’-β-C-Ethynyluridine;3'-C-Ethynyluridine;3’-beta-C-Ethynyluridine;1-(3'-C-ETHYNYL-SS-D-RIBOFURANOSYL)URACIL;1-(3'-C-ETHYNYL-SS-D-RIBOFURANOSYL)URACIL | | CAS: | 180300-49-6 | | MF: | C11H12N2O6 | | MW: | 268.22 | | EINECS: | | | Product Categories: | | | Mol File: | 180300-49-6.mol |  |
| | 3'-beta-C-Ethynyluridine Chemical Properties |
| | 3'-beta-C-Ethynyluridine Usage And Synthesis |
| Uses | 3’-β-C-Ethynyluridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. 3’-β-C-Ethynyluridine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
[2] Connolly GP, et al. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20(5):218-25. DOI:10.1016/s0165-6147(99)01298-5 |
| | 3'-beta-C-Ethynyluridine Preparation Products And Raw materials |
|